Muscular Dystrophy Trial, Recruiting (NCT06574919)

Muscular Dystrophy Trial, Recruiting NCT06574919 Sponsor: Sohag University Condition: Muscular Dystrophy

Printed from Voxsanity (voxsanity.com.au) — NCT06574919 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Muscular Dystrophy

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

Children and teenagers between 2 and 18 years old
People who have been diagnosed with a muscular dystrophy that is not Duchenne Muscular Dystrophy (DMD), confirmed through physical examination, lab tests, and genetic testing
Children whose parents or guardians agree to take part in the study

Who may not be able to join:

Children who have been diagnosed specifically with Duchenne Muscular Dystrophy (DMD)
Children whose medical records are incomplete or whose health information is not fully available
Children who have hormone-related (endocrine), nutritional, or inflammatory muscle conditions, or who are in critical care (confirm with trial site)
Children with certain other conditions affecting the nerves or spinal cord, such as Spinal Muscular Atrophy (SMA), congenital Myasthenia Gravis, or nerve-related disorders
Children with acquired (developed, rather than inherited) muscle or nerve conditions, such as Guillain-Barré Syndrome or toxic myopathy (muscle damage caused by substances)
Children whose parents or guardians do not agree to take part in the study

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 28 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06574919

Sponsor: Sohag University

Phase: Not Applicable

Status: Recruiting

Condition: Muscular Dystrophy

More information: https://clinicaltrials.gov/study/NCT06574919

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

Children and teenagers between 2 and 18 years old
People who have been diagnosed with a muscular dystrophy that is not Duchenne Muscular Dystrophy (DMD), confirmed through physical examination, lab tests, and genetic testing
Children whose parents or guardians agree to take part in the study

Who may not be able to join:

Children who have been diagnosed specifically with Duchenne Muscular Dystrophy (DMD)
Children whose medical records are incomplete or whose health information is not fully available
Children who have hormone-related (endocrine), nutritional, or inflammatory muscle conditions, or who are in critical care (confirm with trial site)
Children with certain other conditions affecting the nerves or spinal cord, such as Spinal Muscular Atrophy (SMA), congenital Myasthenia Gravis, or nerve-related disorders
Children with acquired (developed, rather than inherited) muscle or nerve conditions, such as Guillain-Barré Syndrome or toxic myopathy (muscle damage caused by substances)
Children whose parents or guardians do not agree to take part in the study

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 28 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Sohag University

Registry

ClinicalTrials.gov

Start date

1 August 2024

Est. completion

1 August 2025

Where this trial is recruiting

🇪🇬 Egypt

Primary endpoints

Clinical and Functional Assessment of patients with Inherited Non-Duchenne Myopathies in Sohag University Hospital

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov